HISTONDEMETHYLASEINHIBITOREN

Patent europeic · EP3430008 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3430008
Numer da la dumonda
EP17767452
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
15-03-2017
Publitgà
23-01-2019
Concedì
18-05-2022
Stritgà
25-10-2023
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 471/04 (2006.01)
A61P 35/00 (2006.01)
A61K 31/519 (2006.01)
Prioritad
US 201615071050 15.03.2016
Dumonda PCT
PCT/US2017/022546 15.03.2017
Publicaziun PCT
WO2017/161012 21.09.2017
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 25-10-2023

    Stritgà, taxa betg pajada

    Published in Swissreg on 25.10.2023

  2. 29-03-2023

    Midada

    Published in Swissreg on 29.03.2023

  3. 18-05-2022

    Concedì

    Published in Swissreg on 18.05.2022

Partidas

Possessur

Celgene Quanticel Research, Inc.

9393 Towne Centre Drive, Suite 110, San Diego, CA 92121, US

Inventur

VEAL, James, Marvin

Apex, North Carolina 27502, US

KANOUNI, Toufike

Rancho Santa Fe, CA 92091, US

STAFFORD, Jeffrey, Alan

San Diego, California 92130, US

BOLOOR, Amogh

San Diego, California 92116, US

WALLACE, Michael, Brennan

San Diego, California 92117, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.